{"id":821880,"date":"2025-03-05T07:34:52","date_gmt":"2025-03-05T12:34:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/"},"modified":"2025-03-05T07:34:52","modified_gmt":"2025-03-05T12:34:52","slug":"virax-biolabs-to-present-at-19th-world-immune-regulation-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/","title":{"rendered":"Virax Biolabs to Present at 19th World Immune Regulation Meeting"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">LONDON<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">March 5, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Virax Biolabs Group Limited (&#8220;Virax&#8221; or the &#8220;Company&#8221;) (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that the company&#8217;s management will present at the\u00a019<sup>th<\/sup> World Immune Regulation Meeting (WIRM), which will take place <span class=\"xn-chron\">March 12-15, 2025<\/span>, in <span class=\"xn-location\">Davos, Switzerland<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1879039\/Virax_Biolabs_Logo_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1879039\/Virax_Biolabs_Logo_Logo.jpg\" title=\"(PRNewsfoto\/Virax Biolabs)\" alt=\"(PRNewsfoto\/Virax Biolabs)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>Presentation Details:<\/b>\n      <\/p>\n<p>\n        <b>Title:<\/b><br \/>\n        <i>Evaluation of T cell dysfunction in post acute infection syndromes<br \/><\/i><br \/>\n        <b>Presenter<\/b>:\u00a0Dr. <span class=\"xn-person\">Nigel McCracken<\/span>, Chief Operating Officer at Virax Biolabs<br \/><b>Date<\/b>:\u00a0Wednesday, March 12, 2025, at\u00a020:00<br \/><b>Location<\/b>:\u00a0Foyer A1, The Congress Center,\u00a0Davos, <span class=\"xn-location\">Switzerland<\/span><\/p>\n<p>Additionally, the Company will be showcasing its portfolio of immune profiling products for research use at Booth 116, and management will be available for discussions with research organizations and potential customers.<\/p>\n<p>WIRM 2025 is an esteemed conference where approximately 600 scientists and clinicians from around the globe gather to discuss the latest advancements in immunology. This four-day event combines top-tier scientific lectures, informal networking, and a poster exhibition, all set against the stunning backdrop of <span class=\"xn-location\">Davos<\/span>.<\/p>\n<p>\n        <b>About Virax Biolabs Group Limited<\/b>\n      <\/p>\n<p>Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs Group Limited is currently developing T-Cell-based test technologies with the intention of providing an immunology profiling platform. T-Cell testing can be particularly effective in the diagnosis and therapeutics of post-viral syndromes such as Long COVID and other chronic conditions linked to immune dysregulation.<\/p>\n<p>For more information, please visit\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4376193-1&amp;h=2235600220&amp;u=http%3A%2F%2Fwww.viraxbiolabs.com%2F&amp;a=www.viraxbiolabs.com\" target=\"_blank\" rel=\"nofollow\">www.viraxbiolabs.com<\/a>.<\/p>\n<p>\n        <b>Investor Relations Contact:<\/b>\n      <\/p>\n<p>Russo Partners, LLC<br \/><span class=\"xn-person\">Nic Johnson<\/span><br \/>12 West 27th Street<br \/>4th Floor<br \/><span class=\"xn-location\">New York<\/span>, NY\u00a010001<br \/>M: 303-482-6405<br \/><a href=\"mailto:nic.johnson@russopartnersllc.com\" target=\"_blank\" rel=\"nofollow\">nic.johnson@russopartnersllc.com<\/a>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY33659&amp;sd=2025-03-05\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting-302392440.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting-302392440.html<\/a><\/p>\n<p>SOURCE  Virax Biolabs<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY33659&amp;Transmission_Id=202503050730PR_NEWS_USPR_____NY33659&amp;DateId=20250305\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire LONDON , March 5, 2025 \/PRNewswire\/ &#8212; Virax Biolabs Group Limited (&#8220;Virax&#8221; or the &#8220;Company&#8221;) (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that the company&#8217;s management will present at the\u00a019th World Immune Regulation Meeting (WIRM), which will take place March 12-15, 2025, in Davos, Switzerland. Presentation Details: Title: Evaluation of T cell dysfunction in post acute infection syndromes Presenter:\u00a0Dr. Nigel McCracken, Chief Operating Officer at Virax BiolabsDate:\u00a0Wednesday, March 12, 2025, at\u00a020:00Location:\u00a0Foyer A1, The Congress Center,\u00a0Davos, Switzerland Additionally, the Company will be showcasing its portfolio of immune profiling products for research use at Booth 116, and management will be available for discussions with research organizations and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Virax Biolabs to Present at 19th World Immune Regulation Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-821880","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Virax Biolabs to Present at 19th World Immune Regulation Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Virax Biolabs to Present at 19th World Immune Regulation Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LONDON , March 5, 2025 \/PRNewswire\/ &#8212; Virax Biolabs Group Limited (&#8220;Virax&#8221; or the &#8220;Company&#8221;) (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that the company&#8217;s management will present at the\u00a019th World Immune Regulation Meeting (WIRM), which will take place March 12-15, 2025, in Davos, Switzerland. Presentation Details: Title: Evaluation of T cell dysfunction in post acute infection syndromes Presenter:\u00a0Dr. Nigel McCracken, Chief Operating Officer at Virax BiolabsDate:\u00a0Wednesday, March 12, 2025, at\u00a020:00Location:\u00a0Foyer A1, The Congress Center,\u00a0Davos, Switzerland Additionally, the Company will be showcasing its portfolio of immune profiling products for research use at Booth 116, and management will be available for discussions with research organizations and &hellip; Continue reading &quot;Virax Biolabs to Present at 19th World Immune Regulation Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-05T12:34:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1879039\/Virax_Biolabs_Logo_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Virax Biolabs to Present at 19th World Immune Regulation Meeting\",\"datePublished\":\"2025-03-05T12:34:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1879039\\\/Virax_Biolabs_Logo_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/\",\"name\":\"Virax Biolabs to Present at 19th World Immune Regulation Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1879039\\\/Virax_Biolabs_Logo_Logo.jpg\",\"datePublished\":\"2025-03-05T12:34:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1879039\\\/Virax_Biolabs_Logo_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1879039\\\/Virax_Biolabs_Logo_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Virax Biolabs to Present at 19th World Immune Regulation Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Virax Biolabs to Present at 19th World Immune Regulation Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Virax Biolabs to Present at 19th World Immune Regulation Meeting - Market Newsdesk","og_description":"PR Newswire LONDON , March 5, 2025 \/PRNewswire\/ &#8212; Virax Biolabs Group Limited (&#8220;Virax&#8221; or the &#8220;Company&#8221;) (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that the company&#8217;s management will present at the\u00a019th World Immune Regulation Meeting (WIRM), which will take place March 12-15, 2025, in Davos, Switzerland. Presentation Details: Title: Evaluation of T cell dysfunction in post acute infection syndromes Presenter:\u00a0Dr. Nigel McCracken, Chief Operating Officer at Virax BiolabsDate:\u00a0Wednesday, March 12, 2025, at\u00a020:00Location:\u00a0Foyer A1, The Congress Center,\u00a0Davos, Switzerland Additionally, the Company will be showcasing its portfolio of immune profiling products for research use at Booth 116, and management will be available for discussions with research organizations and &hellip; Continue reading \"Virax Biolabs to Present at 19th World Immune Regulation Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-05T12:34:52+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1879039\/Virax_Biolabs_Logo_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Virax Biolabs to Present at 19th World Immune Regulation Meeting","datePublished":"2025-03-05T12:34:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1879039\/Virax_Biolabs_Logo_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/","name":"Virax Biolabs to Present at 19th World Immune Regulation Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1879039\/Virax_Biolabs_Logo_Logo.jpg","datePublished":"2025-03-05T12:34:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1879039\/Virax_Biolabs_Logo_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1879039\/Virax_Biolabs_Logo_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/virax-biolabs-to-present-at-19th-world-immune-regulation-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Virax Biolabs to Present at 19th World Immune Regulation Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=821880"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821880\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=821880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=821880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=821880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}